Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Running at 40%

Running at 40%

posted on Apr 28, 2008 09:09AM

TPL is selling licenses at a rate that is 40% of last Q.

3 this Q Vs 8 licenses sold last Q, 59 days into the Q.

That's the kind of sales volatility I expected in this business.

The net $ to PTSC per sale is another matter and I expect it to be as volatile as the sales count. The volatility of the net $ per sale could produce favorable or unfavorable results in this Q, or any Q. The size of the companies being licensed could be some indication of net $ income.

The fact that we continue to see sales is good. The rate of sales, although I expected it to be volatile, is not good for this Qs results. The size of the companies licensed this Q is not overly impressive compared to previous Qs. Early Signer's and the J3 deals compound the difficulty of estimating $ per license.

With 33 days to go in this Q, it looks to me to be shaping up to a less than 2 cent EPS Quarter. IMO 2 cents would be good for the SP.

Share
New Message
Please login to post a reply